Adaptive Biotechnologies (ADPT) Gains from Investment Securities (2018 - 2025)
Adaptive Biotechnologies (ADPT) has disclosed Gains from Investment Securities for 8 consecutive years, with $12.8 million as the latest value for Q4 2025.
- Quarterly Gains from Investment Securities rose 106375.0% to $12.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.2 million through Dec 2025, up 876.68% year-over-year, with the annual reading at $205125.0 for FY2025, 98.33% down from the prior year.
- Gains from Investment Securities hit $12.8 million in Q4 2025 for Adaptive Biotechnologies, up from $204587.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $14.1 million in Q2 2023 to a low of -$114000.0 in Q1 2024.
- Historically, Gains from Investment Securities has averaged $3.7 million across 5 years, with a median of $727935.5 in 2024.
- Biggest five-year swings in Gains from Investment Securities: soared 156600.0% in 2023 and later plummeted 2180.0% in 2024.
- Year by year, Gains from Investment Securities stood at $69000.0 in 2021, then crashed by 101.45% to -$1000.0 in 2022, then skyrocketed by 156600.0% to $1.6 million in 2023, then tumbled by 99.23% to $12000.0 in 2024, then skyrocketed by 106375.0% to $12.8 million in 2025.
- Business Quant data shows Gains from Investment Securities for ADPT at $12.8 million in Q4 2025, $204587.0 in Q3 2025, and $203886.0 in Q2 2025.